- Courses by Program
- Community Health
- Environmental Systems & Human Health
- Health Behavior
- Health Management & Policy
- Health Promotion
- Health Services Research
- Health Studies & Public Health Education
- Health Systems & Policy
- Primary Health Care & Health Disparities
- Public Health & Preventive Medicine
- Faculty by Program
- Applied Health & Fitness
- Community Health
- Environmental Systems & Human Health
- Health Management & Policy
- Health Promotion
- Health Studies
- Health Systems & Policy
- Primary Health Care & Health Disparities
- Support Staff
- Uncategorized / Other
Miguel Marino’s research interest lies in population-based studies using large administrative observational data sources and electronic health records. He focuses on development and implementation of novel statistical methodology to address complexities associated with the use of electronic health records to study changes in policy, validation of the electronic reords as a reliable source for observation studies, and design and analysis of cluster-based randomized trials. Marino is also involved in the development of new cardiometabolic risk prediction models for preventive health maintenance and the study of the effect of workplace interventions on sleep and cardiometabolic outcomes. Marino is also the lead biostatistician for the national evaluation of the Agency for Healthcare Research & Quality initiative called EvidenceNOW: Advancing Heart Health in Primary Care.
Along with his research, Marino is interested in mentoring graduate students and teaching statistical principles to non-statistician audiences through OHSU’s clinical and translational science program and social media.
B.S., University of California Los Angeles 2004
M.S., University of California Los Angeles, 2006
Ph.D., Harvard University, 2011
Awards and Honors
- 2013, Junior Researchers Workshop Travel Award, Eastern North American Region, International Biometric Society
- 2012, HSPH Robert Wood Johnson Foundation Seed Grant Award
- 2010, Harvard School of Public Health Teaching Assistant Award
- 2010, Distinguished Student Paper Award, Eastern North American Region, International Biometric Society
- 2010, Best Student Paper Award, American Public Health Association
- R01CA204267-01 (DeVoe)04/01/2016 – 03/31/2021 NCI, ACCESS: Assessing Community Cancer Care after Insurance Expansions ACCESS is a natural experiment to study the impact of increased access to health insurance on cancer screening, preventive services, and cancer survivor care. This study will use EHR data from the ADVANCE clinical data research network of PCORnet to analyze data from CHCs in expansion and non-expansion states.
- U18DP006116-01 (DeVoe) 09/30/2015 – 09/29/2020, CDC/NIDDK PREVENT-D: Post ACA Reform: Evaluate Community Health Center Care for Diabetes This study will measure the impact of Affordable Care Act Medicaid expansions on diabetes mellitus prevention, treatment, expenditures and health outcomes.
- R01HS024270-01 (DeVoe)09/30/2015 – 09/29/2017, AHRQ PACE: Post Affordable Care Act Evaluation of Community Health Centers This study will measure the impact of Affordable Care Act-sponsored Medicaid expansions on access to and utilization of community health center services.
- R01HS022651-02 (DeVoe) 07/10/2015 – 05/31/2019, AHRQEvaluating Community Health Centers’ Adoption of a New Global Capitation Payment (eCHANGE) This study will evaluate the outcomes of the eight Oregon Community Health Centers who participated in an Alternative Payment Methodology demonstration project in which all their Medicaid revenue was paid through a prospective, capitated per-member per-month rate.
- R01HS023940-02 (Cohen) 05/01/2015 – 04/30/2019, AHRQEvaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES) This study will evaluate the R18s funded by AHRQ through RFA-HS-14-008. In this study, we will engage R18 grantees in the overall evaluation by harmonizing measures and working together on data collection and analysis, identify the practice, organization and contextual factors among the combined 2000 practices that are associated with higher and lower levels of deliver of ABCS at baseline (prior to any intervention), identify which intervention strategies implemented by R18 grantees are most effective at improving delivery of ABCS services and practice quality improvement capacity over time and in relation to practice, organization and contextual factors, and identify why some strategies are more effective.
- R01CA181452-03 (DeVoe)07/1/2014 – 06/30/2019, NCI Community-based HIT Tools for Cancer Screening and Health Insurance Promotion The project is a cluster randomized trial in 12 Community Health Centers to test the effectiveness of implementing Community-based HIT Tools for Cancer Screening and Health Insurance Promotion (“CATCHUP” tools) in improving rates of (1) cancer screening and prevention services; and (2) health insurance coverage.
- R01DA031208-05 (Deyo) 02/15/2012 – 01/31/2017, NIDA Use of Prescription Monitoring Programs to Improve Patient Care and Outcomes The overarching goal of this research is to help providers improve the care of complex patients requesting controlled prescription medication. The project involves an evaluation of a newly implemented statewide prescription monitoring program.
- 2U19OH010154-01 (Olson) 09/01/2016 – 08/31/2021 CDC The Oregon Healthy Workforce Center A NIOSH Total Worker Health™ Center of Excellence, the center develops and evaluates workplace interventions to improve safety, health, wellness and well-being. Total Worker Health addresses the needs of the whole person, stresses prevention rather than recovery, and recognizes the great potential of workplace programs to produce organizational and individual behavior change that improves health and reduces accidents. The health of the US population can be improved through prevention, and that is our focus.
Lisa Marriott is a learning and memory researcher and Associate Director of Let’s Get Healthy!, an education and research exhibit that uses health information technology to assess health behaviors and provide immediate, tailored feedback to individuals. The program earned the 2015 Technology Award from the Society of Public Health Education.
Marriott leads teacher professional development programs, most recently on epigenetics, with accompanying published articles in teaching journals that describe lessons and activities for teaching new areas of science to middle and high school students. Her research investigates student pursuance of science careers as well as health-related decision-making using informatics-based approaches.
Marriott also serves as co-director of the OHSU Evaluation Core, where she provides technical assistance and evaluation consultations to researchers and community organizations on educational and health outcomes-focused projects. She has completed two postdoctoral fellowships at OHSU – in physiology and pharmacology and in science education.
B.A., Neuroscience, University of Virginia, 1999
Ph.D., Neuroscience, University of Arizona, 2004
Post-doc, Neuroscience, University of Arizona, 2004
Post-doc, Physiology & Pharmacology, Oregon Health & Science Universtiy, 2004-2007
Post-doc, Science Education, Oregon Health & Science University, 2007-2009
Awards and Honors
2015 Technology Award from the Society of Public Health Education
- R25 OD010496 (Marriott, LK) 04/01/2012-03/31/2017 NIH/ Office of the Director CHIDR Chatter: Translating community research data for classroom use, Role: Principal Investigator
- P30 CA069533 (Druker, B) 06/01/09-09/27/18 NIH/ National Cancer Institute) Administrative Supplements to Expand NCI-supported Community Outreach Capacity through Community Health Educators (CHE) of the National Outreach, Role: Co-Investigator
- BDMS/OHSU International Collaboration (Denny, J.) 12/1/2014-6/30/19 Let’s Get Healthy! Thailand Expansio, Role: Collaborator
- Oregon Health Authority (Fagnan, LJ and McConnell, J, PIs) 6/1/2016-8/1/2017 Sustainable Relationships for Community Health (SRCH) 2016, Role: Evaluator
B.S., Cornell University, 1985
Sc.D., Harvard School of Public Health, 1996
Alison J. Martin is the assessment and evaluation coordinator for the Oregon Center for Children and Youth with Special Health Needs, the state’s Title V block grant agency for children and youth with special health care needs. She is also an evaluation consultant to OHSU’s University Center for Excellence in Developmental Disabilities.
She was a senior social science analyst in the U.S. Government Accountability Office’s Applied Research and Methods team, a research analyst with the Oregon Health Authority’s Maternal and Child Health section, and a senior research associate at RMC Research Corporation. She currently collaborates with nonprofit organizations, providing program evaluation and evaluation capacity building consultation.
Her interests have focused on program evaluation and applied research design and methods, typically of community-based interventions that promote youth wellbeing. Currently, she works on projects that assess the needs of, and promote care coordination for, Oregon children with special health care needs.
B.S., Michigan State University, 1994
M.A., University of Missouri-Kansas City, 1999
Ph.D., University of Missouri-Kansas City, 2003
Awards and Honors
- U.S. General Accounting Office Applied Research and Methods Team Above and Beyond Incentive Award, 2006
- U.S. General Accounting Office Defense Capabilities and Management Team Above and Beyond Incentive Award, 2006
- U.S. General Accounting Office Financial Markets and Community Investment Team Above and Beyond Incentive Award, 2005, 2006
- U.S. General Accounting Office Information Technology Team Incentive Award, 2003
- Psi Chi, National Honor Society of Psychology (1995-Present)
- US Dept of Health & Human Services, Health Research & Services Administration, Sept 1, 2014 – Aug 31, 2017, Enhancing the System of Services for Oregon’s Children and Youth with Special Health Care Needs. Role: Principal Investigator (2016-2017), Program Evaluator (2014-2017)
- Multnomah county SUN Service System, June 2016, Multicultural Feedback on Multnomah County SUN School Food Pantries, Role: Data Analysis Consultant
- Oregon Sexual Assault Task Force, December 2014-January 2015, Program Evaluation Consultation for Oregon SATF, Role: Program Evaluation Technical Assistance Consultant
- Oregon Sexual Assault Task Force, December 2013-April 2014, Program Evaluation Technical Assistance for Oregon CDC Rape Prevention and Education (RPE) Grantees, Role: Program Evaluation Technical Assistance Consultant
- US Dept of Health & Human Services, Substance Abuse and Mental Health Services Administration via Manila Consulting, December 2005-November 2012, National Evaluation of the Safe Schools/Healthy Students Federal Initiative, Role: Associate Director, RMC Research Corp. Subcontract
Dennis McCarty works at the intersection of policy, research and practice as he assesses the organization, financing and quality of prevention and treatment services for alcohol and drug disorders. He serves as the director of the Education Core for the Methamphetamine Abuse Research Center and the co-principal investigator for the Western States Node of the National Drug Abuse Treatment Clinical Trials Network. He is also co-investigator for an evaluation of the impacts of Oregon’s Coordinated Care Organizations on prevention and treatment for alcohol and drug use disorders. He also serves on the Oregon Alcohol and Drug Policy Commission.
From 1989 to 1995, McCarty directed the Massachusetts Bureau of Substance Abuse Services for the Massachusetts Department of Public Health.
B.A., University of Kentucky, 1971
M.A., University of Kentucky, 1976
Ph.D., University of Kentucky, 1978
Post docoral, University of North Carolina, Chapel Hill, 1977 – 1980
Awards and Honors
- 2014, International Award for Excellence in Mentoring, National Institute on Drug Abuse, International Program
- 2012, Lifetime Achievement Award, Alcohol Tobacco and Other Drug Section, American Public Health Association
- 2011, Robert Anderson Award for Research, National Association of State Alcohol and Drug Abuse Directors
- 2007, Fellow, American Psychological Association, Division 28 — Psychopharmacology and Substance Abuse
- 2005, Distinguished Faculty Award for Outstanding Research, OHSU
- Task Order 6 (Chou, Roger) Aug 16 – May 17 AHRQ Naloxone Guidelines for Emergency Medical Technicians, Role: investigator
- UG1 DA015815 (McCarty, Dennis & Sorensen, Jim) Jul 2015 – Jun 2020 NIH/NIDA, Western States Node of the National Drug Abuse Treatment Clinical Trials Network, Role: Co-Principal Investigator
- R33 DA035640 (Rieckmann, Traci) May 2014 – April 2017 NIH/NIDA Oregon’s CCOs integrate care for drug use disorders Role: Investigator
- R01 MH1000001 (McConnell, K. John & Lindrooth, Richard) 2012 – 2017 NIH/NIMH, Evaluating Coordinated Care Organizations, Role: investigator
- P50 DA018165 (Janowsky, Aaron) NIH/NIDA, Methamphetamine Abuse Research Center, Role: Director, Education Core
- R01 DA029716 (McCarty, Dennis) 2011 – 2017, NIH/NIDA, Integrating Addiction Treatment and Medical Care in a Commercial Health Plan, Role: Principal Investigator
- R01 DA030431 (Molfenter, Todd), March 2012 – February 2017, NIH/NIDA, A Payer/Treatment Agency Intervention to Increase Use of Buprenorphine, Role: Investigator
John McConnell is a health economist and director of the Center for Health Systems Effectiveness at OHSU. His research has focused on emergency and trauma care, organizational management, behavioral health and state health policy. A focus of his current work is understanding the effectiveness of reform of the Medicaid payment and delivery system, with Oregon serving as a leading example. His research has been funded by the Agency for Healthcare Research and Quality, the National Institutes of Health and the Robert Wood Johnson Foundation, among others.
As director of the Center for Health Systems Effectiveness, McConnell leads a team focused on developing evidence to improve the value of the health care system. Faculty and staff at the center collaborate with more than 30 faculty across more than a dozen departments in the OHSU School of Medicine, the OHSU-PSU School of Public Health and the Portland VA medical system.
Ph.D., Stanford University, 2001
M.S., Stanford University, 1997
M.A., University of Washington, 1993
B.A., Stanford University, 1990
- National Institute on Minority Health and Health Disparities 1R01MD011212 Assessing the Potential for a State Medicaid Reform Model to Reduce Disparities PI: K. John McConnell Dates: 8/9/2016– 4/30/2020
- National Institute of Mental Health 1R01MH1000001 Evaluating Coordinated Care Organizations PIs: K. John McConnell/Richard C. Lindrooth Dates: 9/7/2012– 7/31/2016
- Agency for Healthcare Research and Quality 1R01HS018466 Management Practices in U.S. Hospitals PI: K. John McConnell Dates: 9/30/2009– 3/31/2013
- National Institute on Drug Abuse 1R01DA024024 Oregon’s Parity Law: Comprehensive Parity in Today’s Healthcare Environment PI: K. John McConnell Dates: 9/28/2007– 8/31/2010
Jessina McGregor is an epidemiologist whose research over the last 10 years or more has focused on antibiotic utilization, antimicrobial stewardship, multidrug-resistant organisms and healthcare-associated infections. McGregor is currently engaged in several federal–, foundation–, and industry-funded research projects, including federally sponsored research that aims to reduce excess fluoroquinolone prescribing for urinary tract infections in primary care settings.
B.A., International Studies, Oregon State University, 2001
B.S., Microbiology, Oregon State University, 2001
Ph.D., Epidemiology, University of Maryland, Baltimore, 2005
- 1 R01 HS022706 – 01A1 (McGregor) 9/30/2014 – 9/29/2017,2.4 calendar months, AHRQ, $288,978, Improving empiric therapy in ambulatory care. Study aims to develop risk score that can inform prudent and appropriate antibiotic selection for uncomplicated urinary tract infections in primary care settings.
- IFRA-0253 (Furuno, McGregor) 7/29/2016 – 7/31/2017 1.0 calendar months Merck, $90,058. A retrospective cohort study of the safety and effectiveness of posaconazole for prophylaxis of invasive fungal infections among immunocompromised patients.
- 1009006_OSU (McGregor/Hartung) 1/1/2016 – 12/31/2021 2.4 calendar months, PCORI $592,227 (Subaward total funding) Peer Review of PCORI’s Funded Research. The purpose of this project is for Dr. McGregor and Dr. Hartung to serve as editors, reviewing and synthesizing reviewer comments, assessing author response and rating reviewers on timeliness and quality as they pertain to PCORI methodology standards. Role: Associate Editor
- HC-1510-06870 (Hartung)10/1/2016-9/30/2018 1.3 calendar months NMSS $411,151 Total Costs, Access, and Value of Multiple Sclerosis Disease-Modifying Therapies Evidence generated from this study can be used by NMSS and other MS stakeholders better advocate for policies to mitigate problems associated with the high costs of DMTs in the US., Role: Co-Investigator
- CMV (Furuno) 1/4/2017-1/3/20180.6 calendar months Merck $94,529 Total. A Retrospective Cohort Study of the Benefits and Burdens of Preemptive Antiviral Therapy for CMV among Hematopoietic Stem Cell Transplant Patients. The goal of this project is to describe transplant modalities, prescribing patterns and clinical characteristics of hematopoietic stem cell transplant (HSCT) patients receiving preemptive antiviral treatment for cytomegalovirus (CMV). Role: Co-Investigator
- No Number (Pakyz) 9/1/2016 – 8/31/20211.8 calendar months CDC, $208,406 (subaward total) Development of NHSN’s AUR data and SAAR to support Antibiotic Benchmarking Program among Vizient Members. The goal of this project is to identify the optimal method for disseminating standardized antibiotic utilization data through usability testing among Vizient [formerly University HealthSystem Consortium (UHC)] members. Role: Subaward PI
Alan Melnick is public health director/health officer for Clark County, Wash., and is an adjunct associate professor at OHSU in the departments of Family Medicine and Public Health & General Preventive Medicine. He is board-certified in Family Medicine and Public Health & General Preventive Medicine. He has served as health officer for several other counties in Oregon and Washington, including Washington, Clackamas and Cowlitz counties and is former director of research for the OHSU Department of Family Medicine.
Melnick is a member of the Board of Trustees of the Washington State Medical Association and member of the Board of Directors of the Washington State Association of Local Public Health Officials. He is a former board member of the National Association of County and City Health Officials.
He has authored two books, numerous other publications and recently published a third book with three coauthors, “Essentials of Public Health Ethics.”
B.A., New York University, 1973
M.D., Tufts University School of Medicine, 1977
M.P.H., University of Washington, 1994
- Anonymous Foundation 2008-2014 Effectiveness of Home Based Distribution of Hormonal Contraception for Women at Risk for Unintended Pregnancy, Role: Principal Investigator
- Robert Wood Johnson Foundation2010-2011 Planning for Active Walkable Neighborhoods, Role: Principal Investigator
- Northwest Health Foundation 2003-2005 Community-based Home Arthritis Management Program for Seniors (CHAMPS), Role: Principal Investigator
- National Institute of Child and Human Development2002-2005 R01 (HD042423-01) Effectiveness of Nurse Home Contraceptive Dispensing, Role: Principal Investigator
- Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment 2002 Opiate Medication Initiative for Rural Oregon Residents (O-MIROR), Role: Medical Co-Director
- Northwest Health Foundation 2002-2003 Clackamas Community Health Mapping Engine”, Role: Principal Investigator
- Northwest Health Foundation (Melnick, PI)1998-1999 Clackamas Care Clinic, Role: Principal Investigator
Jane Mercer has been with the School of Public Health and, before that, with the PSU School of Community Health for more than 30 years.
Her early years at PSU began with teaching Health and Fitness courses. This evolved to include departmental academic advising and finally, becoming internship coordinator. Currently, she teaches Health Promotion Disease Prevention, advises School of Public Health undergraduate students, co-directs student interns and co-chairs the Deadline Appeals Board as well as serving on many additional committees across campus.
Throughout her work with the School of Public Health, Jane’s priority is to assist students with all needs that may arise. On a daily basis, her goal is to work with the students that she teaches and advises in order to improve their individual higher education experience.
M.S.T., Humboldt State University, 1982
California Basic Teaching License, 1982
M.S.T., Portland State University, 1986
Oregon Basic Teaching License, 1986
Awards and Honors
PSU 30 Years of Service Award, 2016
Lynne Messer teaches across the educational spectrum, from undergraduate epidemiology, master’s level women’s health, masters and doctoral health and social inequalities, and doctoral research methods.
Her research explores the intersection of social-environmental justice and residential segregation in exacerbating maternal and child health disparities among vulnerable populations. Her early work focused on better characterizing the built and social environments for population-based epidemiologic disparities research. Her later work incorporated other non-social area-level exposures, including air pollution and environmental contaminants, for maternal and child health. In her current work, she seeks to integrate these related environmental factors with research on fetal development and intergenerational transmission to understand the potential for fetal priming to explain the persistence of health disparities among vulnerable subpopulations.
B.S., University of Oregon, Community Health, 1989
M.P.H., UNC-Chapel Hill, Health Behavior and Health Education, 1995
Ph.D., UNC-Chapel Hill, Epidemiology, 2005
Awards and Honors
- 2016, Dean’s Award for Scholarly Achievement-Junior Faculty
- 2004, Student paper prize, International Conference on Urban Health
- 2003, Student paper prize, International Conference on Urban Health
- 1999-2005, Royster Society of Fellows multiyear doctoral fellowship
- 1995, Delta Omega Society, Theta Chapter
- “Exploring social factors influencing pregnancy outcome disparities among Latinas” Principal Investigator: Lynne C. Messer Mechanism: R21; Project period: 04/01/20160-3/31/2018 Funding: Eunice Kennedy Shriver National Institute of Child Health & Human Development
- “Taking responsible actions in life” Principal investigator: Barbara K Sheppard Role: Evaluation principal investigator Mechanism: 5-year evaluation grant Funding: Office of Adolescent Health; Duration: 07/01/2015-06/30/2020
- “Fetal priming for later-life disparities in allostatic load and heart disease – a data acquisition feasibility pilot” Principal investigator: Lynne C. Messer Funding: Portland State University faculty enhancement grant; Duration: 05/01/2015-04/30/2017
- “Girls on track” Principal investigator: Barbara K. Sheppard Role: Project evaluator Purpose: This project aims to impact region-wide social norms towards positive decision-making that will encourage students to avoid sexual risks. It will adopt a community-wide approach that targets students, parents, and school personnel and will incorporate three major components: sexual education, positive youth development, and parent-child connectedness. Funding: Health and Human Services Funds (evaluation only): $32,000; Duration: 1/1/2013-12/31/2015
- “Pathways to health and well-being: social networks of orphaned and abandoned children” Principal investigator: Lynne C. Messer Purpose: The proposed research sought to identify the composition and variance social network characteristics of OAC, including educational and employment-related supports; identify the sexual network composition and variance characteristics of OAC; and assess the association between the social network characteristics and health-related outcomes (education, income-generation) and between the sexual network characteristics and HIV-risk outcomes. Funding: National Institutes of Health Funds: $274,729; Duration: 04/01/2012 – 03/31/2014 (3/31/2015 – carryforward)
- “Positive outcomes for orphans” Principal investigator: Kathryn Whetten Role: Co-investigator Purpose: This study will continue to follow an existing cohort of more than 3,000 randomly selected orphaned and abandoned children over four years in six culturally diverse study sites in Cambodia, Ethiopia, India (Nagaland and Hyderabad), Kenya, and Tanzania. The objective of the study is to examine the influence of intrapersonal, interpersonal, and community level factors on behavioral relationship outcomes (HIV risk behaviors, reproductive health, and family formation) and achievement outcomes (continued education, income generating activities, and civic engagement). Funding: Eunice Kennedy Shriver National Institute of Child Health & Human Development HIV/AIDS and Orphan Care Funds: $3,397,307; Duration: 09/01/2010 – 08/31/2015
- “Guide to Healing” Principal investigator: Evelyn Byrd Quinlivan Role: Co-investigator and project evaluator Purpose: This project will implement and evaluate a program of primary HIV nursing care to promote medical care engagement and health literacy, provides social support, psychiatric and addiction services on site and employs a nurse guide. Three main interventions will be delivered to HIV+ women of color: 1) rapid linking 2) strengths based counseling and 3) peer-co led supportive-information group with literacy, coping, life skills and social support modules delivered on-site or by phone. Funding: Health Resources and Services Administration Funds: $2,000,000; Duration: 09/01/2009 – 08/31/2014 (8/31/2015 carryforward)
- “Assessing correlated adverse birth outcomes: constructing a bivariate probit model for preterm birth / low birth weight and testing the psychosocial mediation of built environment effects” Principal investigator: Lynne C. Messer Purpose: Using prospective cohort data, Durham County birth records and parcel audit data, the proposed research will construct a bivariate probit model for combined PTB/LBW outcome; examine how neighborhood environments are associated with bivariate PTB/LBW; explore possible differential associations of psychosocial status and bivariate PTB/LBW; and test if maternal psychosocial status mediates the observed relationship between the built environment and the bivariate PTB/LBW outcome Funding: National Institutes of Health (NIH), Health Disparities, Loan Repayment Program Funds: up to $50,000; Duration: 08/01/2011 – 07/31/2013
Marshall Meyer has over 30 years experience teaching health education. He was a full time instructor at Portland Community College for 13 years and also taught classes at PSU and Mt. Hood Community College. Prior to teaching at PCC, Meyer was a program manager at the American Red Cross.
B.S., University of Oregon, 1976
M.S.T., Portland State University, 1983
Randy Miller’s primary interest is in human movement studies, working to understand, improve and enhance methodologies related to exercise prescription and safe, effective program design strategies used to reduce injuries and improve performance in active individuals. He served as the director of the Physical Education program at PSU for almost two decades, where he supervised the Physical Activity courses and instructors.
Miller is a National Strength and Conditioning Association certified strength and conditioning specialist. He currently sits on the NSCA Certification Committee. He has worked with athletes at a local area high school – St. Mary’s Academy – and volunteered as a strength and conditioning coach for the Portland Rockies, a Single A affiliate of Major League baseball’s Colorado Rockies organization. His current research interests include: biomechanics of strength training, functional conditioning and injury prevention, and the use of strength training to prevent injuries and promote better performance.
M.S.T., PSU, 1992
Jessica Minnier is an assistant professor of biostatistics in the School of Public Health and is also affiliated with the Knight Cardiovascular Institute and the Knight Cancer Institute’s Biostatistics Shared Resource.
Minnier maintains a comprehensive statistical research program focusing on the development and evaluation of risk prediction models as well as the analysis of high dimensional data. During her doctoral studies at Harvard University, she developed novel statistical methodology that uses machine-learning techniques to quantify a subject’s risk for disease based on a large number of genetic markers as well as environmental and clinical predictors. As a post-doctoral research fellow at the Fred Hutchinson Cancer Research Institute, she collaborated with geneticists and epidemiologists to analyze genomic and epidemiological data to study colorectal cancer pathogenesis.
Minnier is committed to research that addresses statistical issues related to risk assessment and the role of clinical and genetic predictors in the etiology of disease.
B.A., Mathematics, Lewis & Clark College, 2007
A.M., Biostatistics, Harvard University, 2009
Ph.D., Biostatistics, Harvard University, 2012
Awards and Honors
- 2012, Finalist Best Statistics Student Paper Award, American Public Health Association
- 2011, David P. Byar Travel Award for the Joint Statistical Meetings, American Statistical Association Biometrics Section
- 2011, Rose Traveling Fellowship in Chronic Disease Epidemiology & Biostatistics, Harvard School of Public Health
- 2011, Distinguished Student Paper Award, ENAR International Biometrics Society
- 2006, Barry M. Goldwater Scholar
- U01 CA185094 , NIH/NCI Peters (PI) 09/17/14-08/31/17 Colorectal Tumor Risk Prediction in the PLCO Trial The study will use detailed risk-factor information for colorectal cancer (CRC), including genome-wide genetic data as well as lifestyle and environmental risk factors, to build and validate a comprehensive risk-prediction model using data from a large CRC consortium and the PLCO trial as an independent validation study. As Co-I, I participate in the development of the models and the statistical advisory of the study. Role: Co-Investigator, Site PI
- 14NSBRI1-0025, NSBRI Lindner (PI) 06/01/15-04/30/17 Biomarker assessment for identifying heightened risk for cardiovascular complications during long-duration space missions With the proposed work we will explore new paradigms for: (a) predicting risk for developing atherosclerotic complications in astronauts, (b) monitoring in-flight changes in risk profile that may occur in the setting of deep space exploration, and (c) identifying endothelial susceptibility to the detrimental effects of space radiation. I oversee data collection and processing, coordinate with other statisticians and bioinformaticians on managing the data and performing statistical analyses. Role: Biostatistician
- R01-HL123762, NIH/NHLBI Lindner (PI) 04/12/16-03/31/20 Augmentation of Tissue Perfusion in PAD with Ultrasound-mediated Cavitation The major goal of this project is to explore how ultrasound-mediated cavitation of microbubble contrast agents can produce augmentation in tissue perfusion, and to assess the mechanism by which flow increases. Role: Biostatistician
- R21-NS094833-01, DHHS/NIH/IGNITE Stenzel-Poore (PI) 09/15/16-08/31/17 Development of Poly ICLC for neuroprotection against ischemic brain injury This proposal seeks to advance PolyICLC, a compound that has shown efficacy as a prophylactic treatment in mice, through our novel nonhuman primate stroke model, allowing for eventual translation into patients at risk of brain ischemic injury. Role: Biostatistician
- P30 CA69533-18, NIH/NCI Druker (PI) 07/1/15-06/30/17 OHSU Knight Cancer Institute To support the Cancer Institute at Oregon Health & Science University, its programs, shared resources, and administration. Shared resources include; cancer pathology, flow cytometry, molecular biology, transgenic/gene knockout, gene array, clinical research management, biostatistics and informatics. The instruments of the Institute foster interdisciplinary coordination and collaboration of cancer research faculty at OHSU in basic, clinical, and population research. Role: Faculty
Motomi “Tomi” Mori is a professor of biostatistics in the School of Public Health, a professor in the OHSU School of Medicine’s Department of Medical Informatics & Clinical Epidemiology and director of the Biostatistics Shared Resource at OHSU’s Knight Cancer Institute.
She has published over 130 articles and has 27 years of experience in cancer research. Her current research interest includes clinical trial designs for molecularly targeted agents, biomarker validation and evaluation of personalized medicine in treatment and prevention.
Prior to her time at OHSU and the School of Public Health, Mori was a research assistant professor in the Department of Biostatistics at the University of Washington and a lead biostatistician for the Huntsman Cancer Institute at the University of Utah. She was head of the Division of Biostatistics in the Department of Public Health & Preventive Medicine from 2004 to 2014.
B.A., University of Montana, 1982
M.S., University of Iowa, 1985
Ph.D., University of Iowa, 1989
M.B.A., OHSU-PSU, 2016
Awards and Honors
- 2010, Fellow of the American Statistical Association
- 2005, Outstanding Alumni Award, University of Iowa
- OHSU Knight Cancer Institute (NIH/NCI P30CA069533), Brian Druker (PI), 07/01/2017-06/30/2022
- BEAT-AML: Personalized Medicine for AML Based on Functional Genomics (Leukemia & Lymphoma Society), Brian Druker (PI), 05/01/2013-06/30/2018
- Community-Based HIT Tools for Cancer Screening and Health Insurance Program (NIH/NCI R01CA181452), Jennifer DeVoe (PI), 7/1/2014-6/30/2019
- Proteogenomic Analysis of Drug Response and Resistance in AML to Guide Targeted Therapies (NIH/NCI U01CA214116), Karin Rodland/Brian Druker (PIs), 06/08/2017-06/07/2018
Cynthia Morris is the vice chair and professor of medical informatics and clinical epidemiology, professor of medicine, professor of public health and preventive medicine and assistant dean in the School of Medicine at OHSU. She is also the senior associate director of the Oregon Clinical & Translational Research Institute at OHSU. She directs the education and career development program and co-directs the TL1 and the Master of Clinical Research degree. She also is responsible for the development and implementation of new science, including clinical trials, at the institute.
Morris is the OHSU principal investigator of the BUILD EXITO program at PSU, which works to increase diversity in the scientific research workforce.
Morris is respected for her expertise as a clinical epidemiologist with methodologic expertise in registries, networks, cohort studies and clinical trials. She also founded and maintains the Oregon Registry of Congenital Heart Defects.
B.S., Portland State University, 1977 and 1978
M.P.H., University of Washington, 1982
Ph.D., University of Washington, 1985
Awards and Honors
- 2009, President, Association for Clinical Research Training
- 2007, John Resko Award for Faculty Research and Mentoring
- 2006, Excellence in Education award, OHSU
- 2004, Mentor Award, Medical Research Foundation
- 1K12 HL133115-01 (Newgard and Morris) 8/16/16 – 6/30/21
- 4R01 HL105460-05 (Morris) 6/1/12 – 2/28/22
- 5UL1 GM118964-03 (Crespo) 9/26/14 – 6/30/19
- 1UG3OD023288-01 (McEvoy) 9/21/16-8/31/18
- 3UL1 TR000128-10 (Ellison) 9/30/06-9/30/17
- 3KL2 TR000152-10 (Ellison/Jacoby/Morris) 9/30/06-9/30/17
- 3TL1 TR000129-10 (Ellison/Morris) 9/30/06-9/30/17